FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3208984313> ?p ?o ?g. }

• W3208984313 endingPage "354" @default.
• W3208984313 startingPage "347" @default.
• W3208984313 abstract "BACKGROUND Stroke risk factors after blunt cerebrovascular injury (BCVI) are ill-defined. We hypothesized that factors associated with stroke for BCVI would include medical therapy (i.e., Aspirin), radiographic features, and protocolization of care. METHODS An Eastern Association for the Surgery of Trauma–sponsored, 16-center, prospective, observational trial was undertaken. Stroke risk factors were analyzed individually for vertebral artery (VA) and internal carotid artery (ICA) BCVI. Blunt cerebrovascular injuries were graded on the standard 1 to 5 scale. Data were from the initial hospitalization only. RESULTS Seven hundred seventy-seven BCVIs were included. Stroke rate was 8.9% for all BCVIs, with an 11.7% rate of stroke for ICA BCVI and a 6.7% rate for VA BCVI. Use of a management protocol ( p = 0.01), management by the trauma service ( p = 0.04), antiplatelet therapy over the hospital stay ( p < 0.001), and Aspirin therapy specifically over the hospital stay ( p < 0.001) were more common in ICA BCVI without stroke compared with those with stroke. Antiplatelet therapy over the hospital stay ( p < 0.001) and Aspirin therapy over the hospital stay ( p < 0.001) were more common in VA BCVI without stroke than with stroke. Percentage luminal stenosis was higher in both ICA BCVI ( p = 0.002) and VA BCVI ( p < 0.001) with stroke. Decrease in percentage luminal stenosis ( p < 0.001), resolution of intraluminal thrombus ( p = 0.003), and new intraluminal thrombus ( p = 0.001) were more common in ICA BCVI with stroke than without, while resolution of intraluminal thrombus ( p = 0.03) and new intraluminal thrombus ( p = 0.01) were more common in VA BCVI with stroke than without. CONCLUSION Protocol-driven management by the trauma service, antiplatelet therapy (specifically Aspirin), and lower percentage luminal stenosis were associated with lower stroke rates, while resolution and development of intraluminal thrombus were associated with higher stroke rates. Further research will be needed to incorporate these risk factors into lesion specific BCVI management. LEVEL OF EVIDENCE Prognostic and Epidemiologic, Level IV." @default.
• W3208984313 created "2021-11-08" @default.
• W3208984313 creator A5008696965 @default.
• W3208984313 creator A5012207380 @default.
• W3208984313 creator A5018679010 @default.
• W3208984313 creator A5019706236 @default.
• W3208984313 creator A5023327399 @default.
• W3208984313 creator A5024485769 @default.
• W3208984313 creator A5027363610 @default.
• W3208984313 creator A5028385567 @default.
• W3208984313 creator A5031442379 @default.
• W3208984313 creator A5037565314 @default.
• W3208984313 creator A5037812436 @default.
• W3208984313 creator A5040133548 @default.
• W3208984313 creator A5040682441 @default.
• W3208984313 creator A5046057257 @default.
• W3208984313 creator A5046835755 @default.
• W3208984313 creator A5047073277 @default.
• W3208984313 creator A5055106396 @default.
• W3208984313 creator A5055734010 @default.
• W3208984313 creator A5056395321 @default.
• W3208984313 creator A5061033441 @default.
• W3208984313 creator A5063944902 @default.
• W3208984313 creator A5065294859 @default.
• W3208984313 creator A5068038770 @default.
• W3208984313 creator A5074499092 @default.
• W3208984313 creator A5075087728 @default.
• W3208984313 creator A5078778563 @default.
• W3208984313 creator A5080630760 @default.
• W3208984313 creator A5084746452 @default.
• W3208984313 creator A5088269165 @default.
• W3208984313 creator A5088966403 @default.
• W3208984313 creator A5090448720 @default.
• W3208984313 creator A5090684587 @default.
• W3208984313 date "2021-11-02" @default.
• W3208984313 modified "2023-10-17" @default.
• W3208984313 title "Factors associated with stroke formation in blunt cerebrovascular injury: An EAST multicenter study" @default.
• W3208984313 cites W1722884668 @default.
• W3208984313 cites W1964646281 @default.
• W3208984313 cites W1986020724 @default.
• W3208984313 cites W1988136661 @default.
• W3208984313 cites W1989017334 @default.
• W3208984313 cites W1994633819 @default.
• W3208984313 cites W1995298567 @default.
• W3208984313 cites W2003145817 @default.
• W3208984313 cites W2014731939 @default.
• W3208984313 cites W2032808484 @default.
• W3208984313 cites W2042463018 @default.
• W3208984313 cites W2062193498 @default.
• W3208984313 cites W2069295189 @default.
• W3208984313 cites W2071578081 @default.
• W3208984313 cites W2072828866 @default.
• W3208984313 cites W2082320560 @default.
• W3208984313 cites W2502306375 @default.
• W3208984313 cites W2779773080 @default.
• W3208984313 cites W2785267306 @default.
• W3208984313 cites W2899203063 @default.
• W3208984313 cites W2913265500 @default.
• W3208984313 cites W2995846928 @default.
• W3208984313 cites W4253154321 @default.
• W3208984313 cites W846495029 @default.
• W3208984313 doi "https://doi.org/10.1097/ta.0000000000003455" @default.
• W3208984313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34739003" @default.
• W3208984313 hasPublicationYear "2021" @default.
• W3208984313 type Work @default.
• W3208984313 sameAs 3208984313 @default.
• W3208984313 citedByCount "3" @default.
• W3208984313 countsByYear W32089843132022 @default.
• W3208984313 countsByYear W32089843132023 @default.
• W3208984313 crossrefType "journal-article" @default.
• W3208984313 hasAuthorship W3208984313A5008696965 @default.
• W3208984313 hasAuthorship W3208984313A5012207380 @default.
• W3208984313 hasAuthorship W3208984313A5018679010 @default.
• W3208984313 hasAuthorship W3208984313A5019706236 @default.
• W3208984313 hasAuthorship W3208984313A5023327399 @default.
• W3208984313 hasAuthorship W3208984313A5024485769 @default.
• W3208984313 hasAuthorship W3208984313A5027363610 @default.
• W3208984313 hasAuthorship W3208984313A5028385567 @default.
• W3208984313 hasAuthorship W3208984313A5031442379 @default.
• W3208984313 hasAuthorship W3208984313A5037565314 @default.
• W3208984313 hasAuthorship W3208984313A5037812436 @default.
• W3208984313 hasAuthorship W3208984313A5040133548 @default.
• W3208984313 hasAuthorship W3208984313A5040682441 @default.
• W3208984313 hasAuthorship W3208984313A5046057257 @default.
• W3208984313 hasAuthorship W3208984313A5046835755 @default.
• W3208984313 hasAuthorship W3208984313A5047073277 @default.
• W3208984313 hasAuthorship W3208984313A5055106396 @default.
• W3208984313 hasAuthorship W3208984313A5055734010 @default.
• W3208984313 hasAuthorship W3208984313A5056395321 @default.
• W3208984313 hasAuthorship W3208984313A5061033441 @default.
• W3208984313 hasAuthorship W3208984313A5063944902 @default.
• W3208984313 hasAuthorship W3208984313A5065294859 @default.
• W3208984313 hasAuthorship W3208984313A5068038770 @default.
• W3208984313 hasAuthorship W3208984313A5074499092 @default.
• W3208984313 hasAuthorship W3208984313A5075087728 @default.
• W3208984313 hasAuthorship W3208984313A5078778563 @default.
• W3208984313 hasAuthorship W3208984313A5080630760 @default.
• W3208984313 hasAuthorship W3208984313A5084746452 @default.

• next